Winthrop Advisory Group LLC V Tv Therapeutics Inc. Transaction History

Winthrop Advisory Group LLC

  • $826 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 12, 2022
SELL
$0.95 - $1.69 $2,872 - $5,110
-3,024 Closed
0 $0
Q2 2021

Jul 14, 2021
BUY
$2.27 - $3.44 $878 - $1,331
387 Added 14.68%
3,024 $416,000
Q1 2021

Apr 23, 2021
BUY
$1.97 - $2.89 $230 - $338
117 Added 4.64%
2,637 $347,000
Q4 2020

Jan 25, 2021
BUY
$1.49 - $3.1 $3,754 - $7,812
2,520 New
2,520 $300,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0
View Full List

About vTv Therapeutics Inc.

VTVT Quotes by TradingView
  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.21B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Winthrop Advisory Group LLC Portfolio

Follow Winthrop Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winthrop Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winthrop Advisory Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email